Brainsway (BWAY) Cash from Investing Activities (2018 - 2026)

Brainsway (BWAY) posted quarterly Cash from Investing Activities of -$9.3 million for Q1 2026, down 374.42% year-on-year from $3.4 million in Q1 2025, and down 802.9% on a QoQ basis from -$1.0 million in Q4 2025.

Brainsway (BWAY) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Brainsway (BWAY) has reported Cash from Investing Activities for 9 consecutive years, with -$9.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Investing Activities fell 374.42% year-over-year to -$9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.9 million (down 185.54% YoY) and the FY2025 annual result came in at -$17.5 million, down 157.62% from the prior year.
  • Cash from Investing Activities slipped to -$9.3 million in Q1 2026 per BWAY's latest filing, from -$1.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BWAY reached as high as $40.8 million in Q2 2022 and fell as low as -$35.5 million in Q4 2023.
  • A 5-year average of $485294.1 and a median of -$710000.0 in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 8403.51% — and 2024, when it surged 2363.27%.
  • Year by year, Cash from Investing Activities stood at $427000.0 in 2022, then tumbled by 8403.51% to -$35.5 million in 2023, then jumped by 94.8% to -$1.8 million in 2024, then soared by 43.95% to -$1.0 million in 2025, then slumped by 802.9% to -$9.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$9.3 million, -$1.0 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Brainsway 598.04 Mn 538.27 Mn 11.68 Mn -9.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.33 Mn
Mar 31, 2026 -9.33 Mn
Dec 31, 2025 -1.03 Mn
Dec 31, 2025 -1.03 Mn
Sep 30, 2025 1.37 Mn
Sep 30, 2025 1.37 Mn
Jun 30, 2025 -15.86 Mn
Jun 30, 2025 -15.86 Mn
Mar 31, 2025 -1.97 Mn
Mar 31, 2025 -1.97 Mn
Dec 31, 2024 -1.84 Mn
Dec 31, 2024 -1.84 Mn
Sep 30, 2024 -1.33 Mn
Sep 30, 2024 -1.33 Mn
Jun 30, 2024 34.20 Mn
Jun 30, 2024 34.20 Mn
Mar 31, 2024 -710,000.00
Mar 31, 2024 -710,000.00
Dec 31, 2023 -35.46 Mn
Dec 31, 2023 -35.46 Mn